Table 1.
MSNA (% change) | ΔMAP (mmHg) | ΔHeart rate (beats min−1) | VT (1) | fb (breaths min−1) | T1/TTot | Peak PμM (cm H2O) | ∫PM | ∫PM× fb | VT/TI (1 s−1) | Pco2 (mmHg) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Eupnoea | 0 | 0 | 0 | 0.673 ± 0.196 | 13.3 ± 4.6 | 0.38 ± 0.03 | −0.68 ± 0.28 | −0.68 ± 0.39 | −7.52 ± 4.18 | 0.36 ± 0.06 | 37.8 ± 2.3 |
Protocol 1A | |||||||||||
Min 1 | −3.2 ± 37.3 | 0.9 ± 4.1 | 20.6 ± 9.5* | 1.056 ± 0.282† | 14.9 ± 0.1 | 0.71 ± 0.05† | −68.3 ± 18.0* | −140.9 ± 25.5* | 2073 ± 404* | 0.38 ± 0.11 | 38.2 ± 5.0 |
Min 2 | 22.2 ± 33.6 | 10.1 ± 4.4 | 22.1 ± 9.6* | 1.107 ± 0.295† | 15.0 ± 0.2 | 0.73 ± 0.05† | −70.4 ± 17.9* | −145.9 ± 29.4* | −2177 ± 444* | 0.38 ± 0.11 | 40.2 ± 4.6 |
End | 76.9 ± 51.1* | 12.4 ± 7.4 | 27.0 ± 11.3* | 1.044 ± 0.360† | 15.1 ± 0.5 | 0.71 ± 0.05† | −71.8 ± 17.5* | −131.3 ± 27.4* | −1970 ± 414* | 0.37 ± 0.13 | 41.3 ± 4.5 |
Protocol 1B | |||||||||||
Min 1 | −5.5 ± 21.4 | 1.0 ± 4.2 | 6.0 ± 5.4 | 1.106 ± 0.315† | 15.0 ± 1.4 | 0.64 ± 0.05† | −2.0 ± 0.9 | −1.7 ± 0.8† | −25.1 ± 11.2† | 0.43 ± 0.12 | 40.1 ± 4.4 |
Min 2 | −7.7 ± 18.6 | 1.4 ± 4.2 | 5.7 ± 5.9 | 1.134 ± 0.288† | 15.0 ± 1.2 | 0.65 ± 0.03† | −2.2 ± 0.9 | −1.7 ± 0.8† | −26.3 ± 10.8† | 0.43 ± 0.09 | 41.0 ± 5.5 |
End | −5.5 ± 19.0 | 1.1 ± 3.6 | 4.1 ± 4.7 | 1.114 ± 0.267† | 14.9 ± 1.1 | 0.66 ± 0.05† | −2.1 ± 0.7 | −1.9 ± 0.8† | −27.4 ± 11.4† | 0.42 ± 0.10 | 40.6 ± 4.4 |
Protocol 2A | |||||||||||
Min 1 | −12.1 ± 37.2 | 3.8 ± 1.2† | 20.5 ± 5.9† | 1.221 ± 0.055† | 42.5 ± 2.3† | 0.49 ± 0.01† | −11.0 ± 1.9† | −4.9 ± 0.5† | −206.1 ± 31.6† | 1.78 ± 0.17† | 38.0 ± 6.5 |
Min 2 | 0.4 ± 18.6 | 8.0 ± 3.3† | 16.3 ± 8.9† | 1.237 ± 0.083† | 42.6 ± 2.6† | 0.49 ± 0.01† | −10.2 ± 2.7† | −4.7 ± 1.3† | −199.0 ± 62.1† | 1.79 ± 0.20† | 38.1 ± 4.9 |
Protocol 2B | |||||||||||
Min 1 | −9.8 ± 28.5 | −1.8 ± 7.5 | 6.3 ± 7.8 | 0.933 ± 0.218 | 12.0 ± 0.1 | 0.38 ± 0.08 | −94.7 ± 27.1† | −116.0 ± 32.3† | −1379 ± 380† | 0.49 ± 0.05† | 38.5 ± 3.6† |
Min 2 | 4.4 ± 25.1 | 0.5 ± 5.1 | 9.3 ± 5.0 | 0.970 ± 0.215† | 12.0 ± 0.1 | 0.38 ± 0.08 | −99.3 ± 28.6† | −125.0 ± 30.4† | −1503 ± 348† | 0.51 ± 0.04† | 40.5 ± 4.4 |
Protocol 2C | |||||||||||
Min 1 | −15.7 ± 16.6 | −0.3 ± 4.5 | −0.7 ± 2.1 | 1.270 ± 0.404 | 12.1 ± 0.1 | 0.35 ± 0.04 | −1.9 ± 0.6 | −1.7 ± 1.1 | −20.2 ± 13.0† | 0.67 ± 0.09† | 36.1 ± 0.4 |
Min 2 | 2.9 ± 6.0 | 0.3 ± 2.1 | −0.7 ± 2.5 | 1.187 ± 0.215 | 11.9 ± 0.3 | 0.34 ± 0.08 | −2.0 ± 0.9 | −1.9 ± 1.1 | −23.4 ± 13.8† | 0.68 ± 0.14† | 39.0 ± 4.1 |
Values are means ± S.D. Protocol 1A: 60% MIP + 0.70 duty cycle, fatiguing (n = 7). Protocol 1B: 2% MIP + 0.70 duty cycle, non-fatiguin (n = 7). Protocol 2A: hyperpnoean, non-fatiguing (n = 6). Protocol 2B: 95% MIP + 0.35 duty cycle, non-fatiguing (n = 4). Protocol 2C: 2% MIP + 0.35 duty cycle, non-fatiguin (n = 3).
Significantly different from eupnoea, and from non-fatiguing trial at 2% MIP + 0.70 duty cycle (protocol 1B; P < 0.05).
Significantly different from eupnoea (P < 0.05). End-tidal Po2 averaged 110 mmHg for protocols 1A and 1B and 350 mmHg for protocols 2A, 2B and 2C. ∫PM, integrated mouth pressure; ∫PM × fb, average ∫PM per breath multiplied by breathing frequency.